M. Verlander
We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Expert views
Control strategies for synthetic therapeutic peptide APIs – Part III: Manufacturing process considerations
2014 - I. Eggen, B. Gregg, H. Rode, A. Swietlow, M. Verlander, A. Szajek; BioPharm International, 2014 Read more
Read moreExpert views
Control strategies for synthetic therapeutic peptide APIs – Part II: Raw material considerations
2014 - I. Eggen, B. Gregg, H. Rode, A. Swietlow, M. Verlander, A. Szajek; BioPharm International, May 2014 Read more
Read moreExpert views
Are low-priced peptides affordable?
2006 - M. Verlander, R. Lax; Chimica Oggi/Chemistry Today, Aug 2006 Read more
Read moreExpert views
Large-Scale synthesis of peptides
2000 - L. Andersson, L. Blomberg, M. Flegel, L. Lepsa, B. Nilsson, M. Verlander, Biopolymers (Peptide Science), Nov 2000 Read more
Read more